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Most of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) used in medication have poor water 
solubility and relatively low bioavailability. Many ongoing investigations aim to enhance the 
dissolution rate and solubility of these drugs and thereby reducing the required doses and diminishing 
the risk of side effects. To produce micro- or nanoparticles one of the most popular and efficient 
method is particle size reduction. [1] This method allows us to raise the specific surface of the 
particles which leads to advanced dissolution rate. For nanoparticle generation pulsed laser ablation 
(PLA) is an accepted and popular approach in case of both inorganic and organic materials. [2] Our 
former investigations have shown that PLAL/PLD is a proper technique for the size reduction of 
pharmaceutical particles without causing any chemical decomposition. [3-5] In this work we selected 
three NSAIDs as targets (ibuprofen, niflumic acid and meloxicam) with similar solubility, 
dissociation constant, particle size and crystallinity but with different chemical structures. We studied 
the effect of high-energy pulsed laser beam on the chemical degradation and the size distribution of 
the ablated drug particles. These model medicines are frequently used in acute pain therapy where 
fast absorption through the gastric mucosa is an essential requirement. The solubility of these 
pharmaceuticals is very poor in the gastric juice (pH=1.2) since they have a weak acidic character. 
However, ablated particles dissolve faster and can provide rapid analgesic effect. Our goal was to 
investigate the legitimacy of the PLA method using three different laser wavelengths (248 nm; 532 
nm; 1064 nm) for particle size reduction in ambient gas at standard pressure. We intended to produce 
submicron-sized drug particles, which may form the basis of a new type of pulmonary drug 
formulation for the rapid and efficient therapy of the hard-to-reach alveolar region of the lung. [6] 
 
2. Experimental 
We used commercially available pharmaceutical powders for producing target tablets by a hydraulic 
compactor at 175 MPa pressure:  
Ibuprofen (α-Methyl-4-(isobutyl) phenylacetic acid): white color,  particle size of 15.3 μm (d(0.5)), 
75-77 °C melting point,  157 °C boiling point, 230 °C degradation temperature;   
 
Meloxicam (4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-benzothiazine-3-car-boxamide-1,1-
dioxide): yellow color, particle size of 3.78 μm (d(0.5)), 100% crystalline, 254 °C 
melting/decomposition temperature;  
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Niflumic acid (2-[ [3-(trifluoromethyl)phenyl] amino] -3-pyridinecarboxylic acid, white color, 18.85 
μm (d(0.5)) particle size,   203 °C melting/decomposition temperature. 
 
We investigated the optical absorption coefficient of these three pharmaceuticals by ellipsometry 
(Fig. 1). It can be seen that they have very diverse optical properties at the used wavelengths. 
 
 
Figure 1. Absorption coefficients of ibuprofen (red), niflumic acid (black), and meloxicam (blue) 
 
We irradiated the targets with high-energy (1.5-15 Jcm-2) nanosecond laser impulses in N2 ambient 
gas at standard pressure using the following laser types: KrF excimer laser (FWHM=18 ns, λ=248 
nm, 10 Hz repetition rate) and Nd:YAG laser (FWHM=6 ns, λ=532/1064 nm, 10 Hz repetition rate). 
The laser beam was focused on the target surface at a grazing angle of 45° by focusing lenses. We 
created a N2 gas flow along the chamber at constant flow rate (2 lmin-1). The ablated particles were 
collected for FTIR analysis on a filter (pore size 1 m, Merck Millipore Ltd. Omnipore Membrane 
Filter) (Fig. 2).  
We have also investigated the size distribution of the generated particles by Scanning Mobility 
Particle Sizer (SMPS) by using the same experimental setup as it can be seen in Figure 2. 
 
Figure 2. Experimental setup for PLA of drug pellets. 
Moreover, we set up a generally applied pump and probe system (Fig. 3) for studying the 
material removal process. The pump laser was the above mentioned Nd:YAG laser and as a 
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probe laser we implemented different nitrogen laser induced dye lasers adapting to the ablating 
wavelengths. 
 
Figure 3. Time-resolved investigation of the particle ejections during PLA. 
 
3. Results and discussions 
 
3.1 FTIR Spectroscopy for chemical characterization 
 
FTIR spectra of the ablated particles can be seen in Figure 4. It is observable that the ablation with 
UV (248 nm) laser beam resulted in destroyed particles while with visible (VIS) (532 nm) and IR 
(1064 nm) wavelengths chemically intact particles could be produced in the case of all three drugs. 
For further investigations we used only VIS and IR wavelengths since we intended to avoid chemical 
decomposition of the drugs. 
 
Figure 4. FTIR spectra of ablated drug particles in case of ibuprofen, niflumic acid and meloxicam 
 
3.2 Particle size characterization by SMPS measurements 
 
We investigated the particle size distributions of the ablated products produced at various 
experimental parameters.  The ibuprofen particles were the smallest with having mode values smaller 
than 100 nm in all size distributions. It is followed by niflumic acid and then meloxicam with ≥100 
nm and ~200 nm mode values, respectively. We concluded that no clear dependence on the laser 
fluence can be established. 
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Figure 5. Particle-size measurements of ablated drug particles (ibuprofen, niflumic acid and meloxicam).              
a) Mode values of the particle size distributions at various laser fluences; b) Particle size distributions at 532 nm 
laser wavelength and 6Jcm-2 fluence. 
 
We calculated the penetration depth (d=-1) of the laser light and the temperature rise in the target 




∗ 𝑒−𝛼𝑥 (1), 
where  is the wavelength dependent absorption coefficient, x is the distance from the surface, F is 
the applied fluence of the laser beam,  is the density and c is the specific heat of the target material. 
Our calculations show that the temperatures inside the irradiated volume elements exceed well above 
103 K which means that the chemically intact particles cannot originate from these irradiated volumes. 
This indicates that these particles have to originate from the secondary effects of the ablation e.g. 
photomechanical effects. 
 
3.3 Time-resolved investigation of the particle ejections 
 
To understand and represent the dynamics of particle generation we captured fast photography images 
at different stages of the ablation process (Fig. 6) using VIS laser wavelength and 6 Jcm-2 laser pulses. 
The ablation mechanism was similar for all three drugs. The laser beam induced micro-explosions at 
the target surface triggers the formation of shock waves.  The produced shock wave is followed by 
an expanding cloud of matter in non-condensed state. Due to the recoil forces solid particles 
increasing in size with time start to exit the surface. We could not detect any particles larger than 1 
m with SMPS although it can be clearly seen that particles in all sizes were ablated. It can be related 
to the mass dependence of the mean free path and the limitation of the sizes of transportable particles 
by the magnitude of gas flow. 
 
 
Figure 6. Time-resolved investigation of particle ejection in case of Niflumic acid using 532 nm laser wavelength and 6 
Jcm-2 fluence. 
 
We also estimated the magnitude of photomechanical effects by calculating (equation 2) the initial 




∗ 𝜌 ∗ 𝑣2 (2), 
where P is the pressure produced at the shock front, r is the density of the medium, v is the velocity 
of the shock front and  is the proportion of specific heats (cp/cV) of the medium. The initial pressures 
at the shock fronts are closely equivalent with the recoil pressure of the shock wave what have 70-
350 atm values. It verifies our assumption, that the photomechanical effects have a meaningful role 
in the ablation process of porous materials. 





We can state that PLA is a promising method for the size-reduction of ibuprofen, niflumic acid and 
meloxicam. By the selection of the laser parameters submicron to nanometer size particle managed 
to be generated, lowering the initial sizes of the drugs with orders of magnitude. Only VIS and IR 
laser wavelengths are suitable for producing chemically preserved molecules. The valuable nano- and 
submicron sized particles originate from the secondary photomechanical effects of the ablation.  
We conclude that PLA can offer a chemical-free, reproducible and rather simple approach for the size 
reduction of the investigated NSAIDs. The produced submicron size particles can be beneficiate for 
the development of new pulmonary drug formulations for the medication of the lower lung area in 
pneumonia or severe acute respiratory syndrome. PLA can be advantageous over other generally 
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